Assignee
QUIAPEG PHARMACEUTICALS AB
SE·16 granted patents·5 pending applications·41 citations·filing 2013–2024
Top patents by PatentIndex Score
21 records- 0196US10125220B2Functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2017·Granted Nov 13, 2018·7 cites·19 claims
- 0296US9849187B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2015·Granted Dec 26, 2017·14 cites·34 claims
- 0394US10010621B2Conjugates of biologically active molecules to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2013·Granted Jul 3, 2018·14 cites·16 claims
- 0491US11382984B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2021·Granted Jul 12, 2022·1 cites·20 claims
- 0590US11957735B2Releasable GLP-1 conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2021·Granted Apr 16, 2024·1 cites·20 claims
- 0689US2024075151A1Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2023·Application pending·0 cites
- 0787US10653788B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2019·Granted May 19, 2020·1 cites·20 claims
- 0886US2023285574A1Conjugates of biologically active molecules to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2022·Application pending·0 cites
- 0985US11786599B2Releasable conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2018·Granted Oct 17, 2023·2 cites·27 claims
- 1085US11723981B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2022·Granted Aug 15, 2023·0 cites·20 claims
- 1182US10207007B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2017·Granted Feb 19, 2019·1 cites·20 claims
- 1281US10806796B2Conjugates of biologically active molecules to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2019·Granted Oct 20, 2020·0 cites·23 claims
- 1379US2024181017A1Releasable glp-1 conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2024·Application pending·0 cites
- 1478US11773219B2Functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2020·Granted Oct 3, 2023·0 cites·16 claims
- 1578US11510989B2Conjugates of biologically active molecules to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2020·Granted Nov 29, 2022·0 cites·17 claims
- 1675US10973921B2Conjugates of tumor necrosis factor inhibitors to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2020·Granted Apr 13, 2021·0 cites·20 claims
- 1773US2023381323A1Releasable conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2023·Application pending·0 cites
- 1872US11357828B2Releasable GLP-1 conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2019·Granted Jun 14, 2022·0 cites·23 claims
- 1972US10781286B2Functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2018·Granted Sep 22, 2020·0 cites·20 claims
- 2072US10383946B2Conjugates of biologically active molecules to functionalized polymersQUIAPEG PHARMACEUTICALS AB·Filed 2018·Granted Aug 20, 2019·0 cites·23 claims
- 2151US2021170045A1Releasable antibody conjugatesQUIAPEG PHARMACEUTICALS AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when QUIAPEG PHARMACEUTICALS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →